Astra freeing up cash...
Astra has not done anything at all in term of acquisition and all other players made a move.
Merck deal and HDAC licensing out deal, basically is free-up lots of cash as they will interrupt HDAC program and MEK program.
It's a precursor to an acquistion or many acquisitions.
ASCO was the last hurdle/catalyst for M&A.
Everyone has now all the info. needed for their DD process.
We sit down and wait for decision to be made.
That's about all I could think off for now.